Articles From: Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2013 Financial Results to Ares Capital Corporation Prices Public Offering of $600.0 Million 4.875% Senior Unsecured Notes Due 2018


2013/8/1
-- Second Quarter Highlights Include US launch of BELVIQ® (lorcaserin HCl) CIV for Chronic Weight Management --
Sign-up for Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2013 Financial Results investment picks
2013/11/7
-- Arena and Eisai Expand Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) to Include Most Countries Worldwide -- --
Sign-up for Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results investment picks
2014/2/10
-- BELVIQ Now Covered by CVS Caremark --
Sign-up for Arena Pharmaceuticals Reports Coverage for BELVIQ® (lorcaserin HCl) CIV Now Greater Than 50% of Insured Commercial Lives investment picks
Expansion to Approximately 400 Sales Specialists Follows Increased Coverage of BELVIQ by Health Plans and Pharmacy Benefit Managers SAN DIEGO , Oct.
Sign-up for Arena Pharmaceuticals Reports That Eisai Will Double BELVIQ® (lorcaserin HCl) CIV Sales Force by December investment picks
2013/9/23
SAN DIEGO , Sept.
Sign-up for Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference investment picks
2014/2/5
SAN DIEGO , Feb.
Sign-up for Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences investment picks
2014/2/20
SAN DIEGO , Feb.
Sign-up for Arena Pharmaceuticals to Provide Corporate Update and Report Financial Results on Thursday, February 27 investment picks
2013/12/20
Ares Capital Corporation (NASDAQ: ARCC) announced today that it has acquired a diversified middle-market corporate loan portfolio managed by a global banking institution for approximately $319 million.
Sign-up for Ares Capital Corporation Acquires Diversified Middle Market Loan Portfolio For $319 Million investment picks
2013/9/25
Ares Capital Corporation (Nasdaq:ARCC) announced that it plans to make a public offering of 11,000,000 shares of its common stock.
Sign-up for Ares Capital Corporation Announces Public Offering investment picks
2013/12/9
Ares Capital Corporation (Nasdaq: ARCC) announced that it plans to make a public offering of 14,300,000 shares of its common stock.
Sign-up for Ares Capital Corporation Announces Public Offering investment picks
Ares Capital Corporation (Nasdaq:ARCC) announced today that it closed its public offering of 14,300,000 shares of its common stock on December 13, 2013.
Sign-up for Ares Capital Corporation Closes Public Offering of Common Stock investment picks
Ares Capital Corporation (Nasdaq:ARCC) announced today that it has closed its public offering of 12,650,000 shares of its common stock (including 1,650,000 shares pursuant to the exercise in full by the underwriters of their option to purchase additional shares), raising approximately $214.2 million in net proceeds after deducting underwriting discounts and commissions and estimated offering expenses.
Sign-up for Ares Capital Corporation Closes Public Offering of Common Stock Including Option to Purchase Additional Shares investment picks
2014/2/26
Ares Capital Corporation (“Ares Capital”) (NASDAQ:ARCC) announced that its Board of Directors has declared a first quarter dividend of $0.38 per share, payable on March 31, 2014 to stockholders of record as of March 14, 2014.
Sign-up for Ares Capital Corporation Declares First Quarter 2014 Dividend of $0.38 Per Share and Announces December 31, 2013 Financial Results investment picks
2013/11/5
Ares Capital Corporation (“Ares Capital”) (NASDAQ: ARCC) announced that its Board of Directors has declared the following dividends: (i) a fourth quarter dividend of $0.38 per share payable on December 31, 2013 to stockholders of record as of December 16, 2013, (ii) an additional dividend of $0.05 per share payable on December 31, 2013 to stockholders of record as of December 16, 2013 and (iii) another additional dividend of $0.05 per share payable on March 28, 2014 to stockholders of record as of March 14, 2014.
Sign-up for Ares Capital Corporation Declares Fourth Quarter 2013 Dividend of $0.38 Per Share and Two Additional Dividends of $0.05 Per Share and Announces September 30, 2013 Financial Results investment picks
Ares Capital Corporation (“Ares Capital”) (NASDAQ: ARCC) announced that its Board of Directors has declared a third quarter dividend of $0.38 per share, payable on September 30, 2013 to stockholders of record as of September 16, 2013.
Sign-up for Ares Capital Corporation Declares Third Quarter 2013 Dividend of $0.38 Per Share and Announces June 30, 2013 Financial Results investment picks
2014/3/28
Ares Capital Corporation (NASDAQ:ARCC) announced today that its investment adviser, Ares Capital Management LLC, has added two investment professionals as part of its expansion of its middle market sponsor coverage strategy.
Sign-up for Ares Capital Corporation Enhances Sponsor Coverage investment picks
2014/3/24
Ares Capital Corporation (NASDAQ:ARCC) announced today that its investment adviser, Ares Capital Management LLC, has added two investment professionals as part of an expansion of its energy lending capabilities.
Sign-up for Ares Capital Corporation Expands Energy Finance Capabilities investment picks
2014/4/1
Ares Capital Corporation (NASDAQ:ARCC) announced today that it has amended and extended its senior secured revolving credit facility with its existing bank group of eighteen lenders.
Sign-up for Ares Capital Corporation Extends and Upsizes Revolving Credit Facility investment picks
2014/2/26
Ares Capital Corporation (NASDAQ:ARCC) is providing additional details on five of its financing commitments closed during the fourth quarter of 2013, which were included in Ares Capital’s earnings announcement released earlier today.
Sign-up for Ares Capital Corporation Highlights Select Financing Commitments Closed During the Fourth Quarter investment picks
2013/8/6
Ares Capital Corporation (NASDAQ: ARCC) announced today that it is providing additional details on three of its financing commitments closed during the second quarter of 2013, which were included in this morning’s previously released earnings announcement.
Sign-up for Ares Capital Corporation Highlights Select Financing Commitments Closed During the Second Quarter investment picks
2013/11/5
Ares Capital Corporation (NASDAQ: ARCC) is providing additional details on four of its financing commitments closed during the third quarter of 2013, which were included in this morning’s earnings announcement.
Sign-up for Ares Capital Corporation Highlights Select Financing Commitments Closed During the Third Quarter investment picks
Ares Capital Corporation (Nasdaq:ARCC) announced that it has priced its public offering of 11,000,000 shares of its common stock.
Sign-up for Ares Capital Corporation Prices Public Offering investment picks
2013/12/10
Ares Capital Corporation (Nasdaq: ARCC) announced that it has priced its public offering of 14,300,000 shares of its common stock.
Sign-up for Ares Capital Corporation Prices Public Offering investment picks
Ares Capital Corporation (Nasdaq:ARCC) announced that it has priced an underwritten public offering of $600.0 million in aggregate principal amount of 4.875% senior unsecured notes due 2018.
Sign-up for Ares Capital Corporation Prices Public Offering of $600.0 Million 4.875% Senior Unsecured Notes Due 2018 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2013 Financial Results to Ares Capital Corporation Prices Public Offering of $600.0 Million 4.875% Senior Unsecured Notes Due 2018
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity